Olga Salamero

2.8k citations
46 papers · 890 indexed · h-index 13
Topics
Acute Myeloid Leukemia Research (30 papers)Chronic Lymphocytic Leukemia Research (9 papers)Histone Deacetylase Inhibitors Research (9 papers)

In The Last Decade

Olga Salamero

43 papers receiving 878 citations

Peers

Olga Salamero
Comparison fields: 5 of 51
  • Hematology 625
  • Molecular Biology 381
  • Genetics 282
  • Public Health, Environmental and Occupational Health 180
  • Oncology 167
Replace Paulo Lúcio with:
Paulo Lúcio Portugal
Susana Vives Spain
Deborah Fuchs United States
Yue‐Yun Lai China
Valentina Gianfelici Italy
Javier Fernández‐Calvo Spain
Olga Gielen Belgium
Joseph O. Moore United States
Eri Kawata Japan
T. Karakas Germany
Olga Salamero relative to Paulo Lúcio Portugal Paulo Lúcio's profile →
Citations per field
00.5×3.6×
Paulo Lúcio · 1×
Citations per year

Countries citing papers authored by Olga Salamero

Since Specialization
Citations

This map shows the geographic impact of Olga Salamero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Salamero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Salamero more than expected).

Fields of papers citing papers by Olga Salamero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Salamero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Salamero. The network helps show where Olga Salamero may publish in the future.

Co-authorship network of co-authors of Olga Salamero

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Salamero. A scholar is included among the top collaborators of Olga Salamero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Salamero. Olga Salamero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 9
3 18
4 19
5 2
6 5
7 9
8 45
9 49
10 25
11 11
12 2
13 10
14 4
15 4
16 32
17 12
18 89
19 10
20 3

About Olga Salamero

Olga Salamero is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 46 papers that have together received 890 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Histone Deacetylase Inhibitors Research (9 papers). The work is most often cited by research in Hematology (625 citations), Genetics (282 citations) and Pathology and Forensic Medicine (143 citations). Olga Salamero has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Francesc Bosch, Jorge Sierra, Jordi Esteve, Emili Montserrat, Lourdes Escoda, Montserrat Hoyos, Josep Nomdedéu, Salut Brunet, Josep‐María Ribera and Rafael F. Duarte. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026